Former Lilly neuroscience chief heads to J&J

Tuesday, March 8, 2011 11:08 AM

Former Eli Lilly neuroscience chief David Bredt’s recent resignation was not due to the company's setbacks in that field, according to FierceBiotech. Bredt has landed a new job in the neuroscience research group at Johnson & Johnson, which is looking to advance its own pipeline of drugs for Alzheimer's and other neurological diseases.

Bredt was sought after by the global head of neuroscience at J&J, Husseini Manji. "We think the science is exploding, and we can enhance our efforts," Manji said in an interview with the Wall Street Journal Health Blog.

Bredt will oversee development of new drugs and "ways for measuring their worth, such as biomarkers and animal models for testing the molecules," according to the WSJ report.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs